115 related articles for article (PubMed ID: 10338085)
1. Dipeptidyl peptidase IV (DPP IV/CD26) staining predicts distant metastasis of 'benign' thyroid tumor.
Hirai K; Kotani T; Aratake Y; Ohtaki S; Kuma K
Pathol Int; 1999 Mar; 49(3):264-5. PubMed ID: 10338085
[TBL] [Abstract][Full Text] [Related]
2. [CD26/dipeptidyl peptidase IV and thyroid peroxidase as molecular markers for differentiated thyroid carcinoma].
Umeki K; Yamamoto I; Maruta J; Aratake Y; Ono I; Uemura Y; Tanaka T; Toyoda K; Kotani T; Noguchi S; Sakamoto F; Konoe K; Ohtaki S
Rinsho Byori; 1996 Jan; 44(1):42-50. PubMed ID: 8691639
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of dipeptidyl peptidase IV (CD26) and thyroid peroxidase in neoplastic thyroid tissues.
Umeki K; Tanaka T; Yamamoto I; Aratake Y; Kotani T; Sakamoto F; Noguchi S; Ohtaki S
Endocr J; 1996 Feb; 43(1):53-60. PubMed ID: 8732452
[TBL] [Abstract][Full Text] [Related]
4. CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma.
Tanaka T; Umeki K; Yamamoto I; Sakamoto F; Noguchi S; Ohtaki S
Int J Cancer; 1995 Oct; 64(5):326-31. PubMed ID: 7591305
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Arch Surg; 2004 Jan; 139(1):83-8. PubMed ID: 14718282
[TBL] [Abstract][Full Text] [Related]
6. Decrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines.
Fröhlich E; Engel E; Wahl R
Horm Metab Res; 2011 May; 43(5):364-6. PubMed ID: 21412686
[TBL] [Abstract][Full Text] [Related]
7. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma.
Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C
Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915
[TBL] [Abstract][Full Text] [Related]
8. Examination of CD26/DPPIV, p53, and PTEN expression in thyroid follicular adenoma.
Miyake Y; Aratake Y; Sakaguchi T; Kiyoya K; Kuribayashi T; Marutsuka K; Ohno E
Diagn Cytopathol; 2012 Dec; 40(12):1047-53. PubMed ID: 22086610
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours.
Kotani T; Asada Y; Aratake Y; Umeki K; Yamamoto I; Tokudome R; Hirai K; Kuma K; Konoe K; Araki Y
J Pathol; 1992 Sep; 168(1):41-5. PubMed ID: 1360496
[TBL] [Abstract][Full Text] [Related]
10. Altered peptidase activities in thyroid neoplasia and hyperplasia.
Larrinaga G; Blanco L; Errarte P; Beitia M; Sanz B; Perez I; Irazusta A; Sánchez CE; Santaolalla F; Andrés L; López JI
Dis Markers; 2013; 35(6):825-32. PubMed ID: 24379520
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of dipeptidyl peptidase IV (CD 26) in thyroid neoplasia using biotinylated tyramine amplification.
Kholová I; Ludvíková M; Ryska A; Hanzelková Z; Cap J; Pecen L; Topolcan O
Neoplasma; 2003; 50(3):159-64. PubMed ID: 12937847
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic role of markers dipeptidyl peptidase IV and thyroid peroxidase in thyroid tumors.
Kholová I; Ludvíkova M; Ryska A; Topolcan O; Pikner R; Pecen L; Cáp J; Holubec L
Anticancer Res; 2003; 23(2A):871-5. PubMed ID: 12820316
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
14. CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma.
Tomoda C; Kushima R; Takeuti E; Mukaisho K; Hattori T; Kitano H
Thyroid; 2003 Mar; 13(3):291-5. PubMed ID: 12729479
[TBL] [Abstract][Full Text] [Related]
15. HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm.
Mase T; Funahashi H; Koshikawa T; Imai T; Nara Y; Tanaka Y; Nakao A
Endocr J; 2003 Apr; 50(2):173-7. PubMed ID: 12803237
[TBL] [Abstract][Full Text] [Related]
16. [Dipeptidyl(amino)peptidase IV in the differential diagnosis of thyroid gland tumors: methods and results of a pilot study of 200 cases].
Kholová I; Ludvíková M; Ryska A; Cáp J
Cesk Patol; 2002 Jan; 38(1):11-7. PubMed ID: 11933456
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases.
Aratake Y; Kotani T; Tamura K; Araki Y; Kuribayashi T; Konoe K; Ohtaki S
Am J Clin Pathol; 1991 Sep; 96(3):306-10. PubMed ID: 1715126
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma.
González-Cámpora R; Galera-Ruiz D; Armas-Padrón JR; Otal-Salaverri C; Galera-Davidson H
Diagn Cytopathol; 1998 Jul; 19(1):4-8. PubMed ID: 9664176
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase IV expression in thyroid cytology: retrospective histologically confirmed study.
Kholová I; Ryska A; Ludvíková M; Cáp J; Pecen L
Cytopathology; 2003 Feb; 14(1):27-31. PubMed ID: 12588307
[TBL] [Abstract][Full Text] [Related]
20. Vascular and capsular pseudoinvasion in thyroid neoplasms.
Chebib I; Opher E; Richardson ME
Int J Surg Pathol; 2009 Dec; 17(6):449-51. PubMed ID: 19666948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]